Improving Patient Outcomes and Reducing Inefficiency
Concern over rising health care costs has increased interest in promoting high-quality care, while avoiding low value or inefficient care. As the U.S. health care system encourages value-driven decision-making, it is important that information on value of health care interventions be robust, transparent and address the needs of all health care stakeholders, including patients, payers and providers.
A number of initiatives aiming to drive value in health care have emerged in recent years, but few offer transformative solutions that reflect patient preferences and real-world clinical practice. In addition, many issues in methodology and patient engagement remain unresolved.
To address these factors and encourage patient-centered, value-driven care, the PhRMA Foundation’s Value Assessment Initiative (VAI) offers special research awards — with total funding of more than $1.4 million to date.
This major initiative is seeking transformative, multi-stakeholder-driven solutions to address challenges in assessing the value of medicines and health care services to improve patient outcomes and reduce inefficiency.
The initiative offers three separate award programs: Center of Excellence Awards, Research Awards and Challenge Awards.
Note: Applications are now closed for the current cycle of funding for Value Assessment Awards. Information about the next round of funding – for 2019 and 2020 — will be posted at this website in early 2019.
In the meantime, if you would like to learn more about the process of applying for a Value Assessment Award, please click on any of the designated green boxes below.
You can also download our current application guidelines for the three awards, below. Please note that these are guidelines for the current funding cycle, which is now closed. To view our updated application guidelines for the next funding cycle, please visit this website again in early 2019.
An Advisory Committee has been established to help lead this initiative. To learn about the Advisory Committee, click here.